Logo image of TIC

ACUREN CORPORATION (TIC) Stock Fundamental Analysis

USA - NYSE:TIC - US00510N1028 - Common Stock

13.09 USD
+0.34 (+2.67%)
Last: 10/14/2025, 8:21:26 PM
12.9 USD
-0.19 (-1.45%)
After Hours: 10/14/2025, 8:21:26 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to TIC. TIC was compared to 82 industry peers in the Professional Services industry. The financial health of TIC is average, but there are quite some concerns on its profitability. TIC is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

TIC had negative earnings in the past year.
TIC Yearly Net Income VS EBIT VS OCF VS FCFTIC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

TIC has a worse Return On Assets (-5.40%) than 74.39% of its industry peers.
With a Return On Equity value of -10.28%, TIC is not doing good in the industry: 69.51% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -5.4%
ROE -10.28%
ROIC N/A
ROA(3y)-1.48%
ROA(5y)N/A
ROE(3y)-2.78%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TIC Yearly ROA, ROE, ROICTIC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 -5 -10

1.3 Margins

The Gross Margin of TIC (24.21%) is worse than 68.29% of its industry peers.
The Profit Margin and Operating Margin are not available for TIC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TIC Yearly Profit, Operating, Gross MarginsTIC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 10 -10 20

More info and screens

5

2. Health

2.1 Basic Checks

TIC does not have a ROIC to compare to the WACC, probably because it is not profitable.
TIC has less shares outstanding than it did 1 year ago.
Compared to 1 year ago, TIC has an improved debt to assets ratio.
TIC Yearly Shares OutstandingTIC Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M 40M 50M
TIC Yearly Total Debt VS Total AssetsTIC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 1.99 indicates that TIC is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of TIC (1.99) is worse than 63.41% of its industry peers.
TIC has a Debt/Equity ratio of 0.67. This is a neutral value indicating TIC is somewhat dependend on debt financing.
TIC's Debt to Equity ratio of 0.67 is on the low side compared to the rest of the industry. TIC is outperformed by 60.98% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Altman-Z 1.99
ROIC/WACCN/A
WACC8.4%
TIC Yearly LT Debt VS Equity VS FCFTIC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

TIC has a Current Ratio of 3.35. This indicates that TIC is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of TIC (3.35) is better than 89.02% of its industry peers.
TIC has a Quick Ratio of 3.35. This indicates that TIC is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.35, TIC belongs to the best of the industry, outperforming 90.24% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.35
Quick Ratio 3.35
TIC Yearly Current Assets VS Current LiabilitesTIC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 100M 200M 300M

More info and screens

4

3. Growth

3.1 Past

TIC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -749.27%.
The Revenue has been growing slightly by 4.51% in the past year.
EPS 1Y (TTM)-749.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)4.51%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, TIC will show a very strong growth in Earnings Per Share. The EPS will grow by 35.45% on average per year.
TIC is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 29.40% yearly.
EPS Next Y117.35%
EPS Next 2Y50.06%
EPS Next 3Y35.45%
EPS Next 5YN/A
Revenue Next Year44.25%
Revenue Next 2Y43.73%
Revenue Next 3Y29.4%
Revenue Next 5YN/A

3.3 Evolution

TIC Yearly Revenue VS EstimatesTIC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
TIC Yearly EPS VS EstimatesTIC Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0.1 0.2 0.3 0.4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TIC. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 52.54 indicates a quite expensive valuation of TIC.
Based on the Price/Forward Earnings ratio, TIC is valued a bit more expensive than the industry average as 64.63% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.99, TIC is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 52.54
TIC Price Earnings VS Forward Price EarningsTIC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

TIC's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. TIC is more expensive than 71.95% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 37.22
TIC Per share dataTIC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

TIC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
TIC's earnings are expected to grow with 35.45% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.06%
EPS Next 3Y35.45%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TIC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ACUREN CORPORATION

NYSE:TIC (10/14/2025, 8:21:26 PM)

After market: 12.9 -0.19 (-1.45%)

13.09

+0.34 (+2.67%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)N/A N/A
Inst Owners52.65%
Inst Owner ChangeN/A
Ins Owners9.89%
Ins Owner Change33.45%
Market Cap2.63B
Analysts80
Price Target14.79 (12.99%)
Short Float %4.14%
Short Ratio2.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend2.78
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-693.07%
Min EPS beat(2)-1286.14%
Max EPS beat(2)-100%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.14%
Min Revenue beat(2)0.78%
Max Revenue beat(2)3.49%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)4.82%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-11.98%
EPS NY rev (1m)440%
EPS NY rev (3m)-60.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)51.3%
Revenue NY rev (1m)0.19%
Revenue NY rev (3m)38.01%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 52.54
P/S 2.39
P/FCF N/A
P/OCF N/A
P/B 2.23
P/tB N/A
EV/EBITDA 37.22
EPS(TTM)-0.99
EYN/A
EPS(NY)0.25
Fwd EY1.9%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS5.47
BVpS5.88
TBVpS-2.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.4%
ROE -10.28%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.21%
FCFM N/A
ROA(3y)-1.48%
ROA(5y)N/A
ROE(3y)-2.78%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Debt/EBITDA 9.03
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.35
Quick Ratio 3.35
Altman-Z 1.99
F-ScoreN/A
WACC8.4%
ROIC/WACCN/A
Cap/Depr(3y)26.56%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.37%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-749.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y117.35%
EPS Next 2Y50.06%
EPS Next 3Y35.45%
EPS Next 5YN/A
Revenue 1Y (TTM)4.51%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year44.25%
Revenue Next 2Y43.73%
Revenue Next 3Y29.4%
Revenue Next 5YN/A
EBIT growth 1Y-111.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year4279.84%
EBIT Next 3Y314.79%
EBIT Next 5YN/A
FCF growth 1Y-106.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-75.92%
OCF growth 3YN/A
OCF growth 5YN/A